DISEASE CONTROL & ELIMINATION SEED FUNDING

Mark Thursz

Prolifica (Prevention of Liver Fibrosis and Cancer in Africa)

Liver and intrahepatic bile ducts

Pathology

Ramou Njie

Gambia Hepatitis Intervention Study

Liver and intrahepatic bile ducts

Pathology

Anneke Catharina Hesseling

PHARMACOKINETICS AND TOXICITY OF 2ND LINE ANTI-TB DRUGS IN HIV-INFECTED CHILDREN

Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Kaposi sarcoma Hodgkin lymphoma

Hematology and hematologic malignancies

Xin Wei Wang

Molecular signatures for liver cancer diagnosis and treatment stratification

Liver and intrahepatic bile ducts

Pathology

Demetrius Albanes

Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study

Trachea, bronchus and lung Testis Stomach Prostate Pancreas Oesophagus Non-Hodgkin lymphoma Liver and intrahepatic bile ducts Leukaemia Larynx Kidney, renal pelvis and ureter Colorectum Brain, nervous system Bladder

Pathology

Jean-Francois H Geschwind

See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization DrugDelivery

Liver and intrahepatic bile ducts

Pathology

Dean W Felsher

Mechanisms by which Oncogene Inactivation Elicits Tumor Cell Death

Sarcoma Liver and intrahepatic bile ducts Leukaemia

Patricia Steeg

Molecular Biology of the Metastatic Phenotype

Trachea, bronchus and lung Liver and intrahepatic bile ducts Breast All cancers but non-melanoma skin cancer

Pathology

John Tavis

N-hydroxyisoquinolinediones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology